NCT00306644已完成4 期
Effect of Rosiglitazone and Placebo on Carotid Intima Media Thickness in Patients With Insulin Resistance Syndrome and/or Type 2 Diabetes
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 556
- 试验地点
- 1
- 主要终点
- Change from baseline of the composite intima-media thickness (IMT) in the carotid artery following 52 weeks of treatment.
研究概览
简要总结
The study investigated the effect of rosiglitazone and placebo on carotid intima media thickness in patients with insulin resistance syndrome and/or type 2 diabetes.
详细描述
RAS Rosiglitazone and Atherosclerosis Study: A 1 year randomised, double-blind, parallel group, placebo controlled study to evaluate the efficacy of rosiglitazone on the progression of intima-media thickness in the carotid artery in subjects with insulin resistance syndrome and/or type 2 diabetes mellitus
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 35 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Arm 1
Experimental
study drug
干预措施: Rosiglitazone (Drug)
结局指标
主要结局
Change from baseline of the composite intima-media thickness (IMT) in the carotid artery following 52 weeks of treatment.
时间窗: 52 weeks
次要结局
- Plaque occurrence & stenosis within the right carotid artery.(52 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial TriglycerideDiabetes Mellitus, Type 2NCT00424762University of Texas Southwestern Medical Center150
已完成
不适用
Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease PatientsEndstage Renal DiseaseDiabetesNCT00745914The University of Hong Kong22
已完成
不适用
Effects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High CholesterolHypercholesterolemiaHypertensionNCT00006071National Heart, Lung, and Blood Institute (NHLBI)120
已完成
不适用
Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood VesselsAtherosclerosisHIV InfectionsNCT00143624University of British Columbia50
已完成
不适用
Effect of Rosiglitazone on Vascular Function in Patients with Advanced Chronic Kidney DiseaseAdvanced Chronic kidney diseaseVascular functionRenal and Urogenital - Kidney diseaseACTRN12605000690651Raine Medical Research foundation (pending)70